Understanding and targeting tau protein changes in Alzheimer's disease
Characterizing and Targeting Filament Polymorphism in Tauopathies
This study is looking at how the tau protein changes in people with Alzheimer's disease to find new ways to treat it, and it's for anyone affected by this condition who hopes for better therapies.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10868473 on NIH RePORTER |
What this research studies
This research investigates the structural changes in tau protein aggregates that are associated with Alzheimer's disease, a common form of dementia. Using advanced techniques like cryoelectron microscopy, the study aims to uncover how these tau aggregates differ in structure and how these differences could be targeted for therapeutic purposes. By identifying unique features of tau polymorphs, the research seeks to develop specific chemical probes that could lead to new treatment strategies for patients suffering from tauopathies. The findings could provide critical insights into the underlying mechanisms of Alzheimer's disease and pave the way for innovative therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related tauopathies.
Not a fit: Patients with non-tauopathies or other forms of dementia unrelated to tau protein aggregation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new targeted treatments for Alzheimer's disease, potentially improving outcomes for patients.
How similar studies have performed: Previous research has shown promise in targeting protein aggregates in neurodegenerative diseases, suggesting that this approach could yield significant advancements.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Malyshka, Dmitry — Ohio State University
- Study coordinator: Malyshka, Dmitry
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.